Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1441-1460 of 1,549 trials

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

NCT01013480

Study 22001, "A Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects with Fragile X Syndrome" currently is evaluating the efficacy of STX209 (R-baclofen) for management of typical problem behaviors, such as irritability and aggression, in subjects with FXS. This study (22002) will enter subjects who complete Study 22001 into a long-term, open-label study.The open-label extension protocol will provide necessary data on the long-term safety and tolerability of STX209 among subjects with FXS who receive treatment under conditions more closely reflective of their general medical care.

Fragile X Syndrome

Seaside Therapeutics, Inc.45 participantsStarted Nov 2009

Los Angeles, California, United States • Sacramento, California, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDPhase 2< 1 mile

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study of NP001 in subjects with ALS.

Amyotrophic Lateral Sclerosis

Neuraltus Pharmaceuticals, Inc.136 participantsStarted Feb 2011

Scottsdale, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +14 more locations

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Rheumatoid Arthritis Trials in Other Cities

An Implantable Spinal Cord Stimulation Pain Management System

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

Belatacept in Liver Transplant Recipients

Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection

Effect of Sugared Chewing Gum on Gastrointestinal Recovery After Major Colorectal Surgery

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis

FS VH S/D 500 S-apr in Vascular Surgery

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Acute Cough Study In Children

Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)

Other Conditions in Los Angeles